XM does not provide services to residents of the United States of America.
S
S

Steris

News

STERIS plc reports results for the quarter ended in January - Earnings Summary

STERIS plc reports results for the quarter ended in January - Earnings Summary STERIS plc STE.N reported quarterly adjusted earnings of $2.14​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $2.00. The mean expectation of seven analysts for the quarter was for earnings of $1.98 per share.
S

Steris beats first-quarter estimates on strong demand for medical procedures

Steris beats first-quarter estimates on strong demand for medical procedures Aug 6 (Reuters) - Steris STE.N reported better-than-expected profit and revenue for the first quarter on Tuesday, as strong demand for non-urgent medical procedures lifted sales of its surgical and examination tools. The Dublin, Ireland-based company, which offers devices such as surgical tables, examination lights and endoscope, has been seeing strong sales of its products since late last year as more people opt for su
S

Steris Q1 Adjusted EPS USD 2.03 Vs. IBES Estimate USD 1.98

BRIEF-Steris Q1 Adjusted EPS USD 2.03 Vs. IBES Estimate USD 1.98 Aug 06 (Reuters) - Steris Q1 revenue USD 249.8 million vs. IBES estimate USD 1,272 million. Q1 adjusted net income USD 201.7 million vs. IBES estimate USD 197.6 million Q1 net income USD 139.9 million outlook FY free cash flow USD 700 million
S

Rollercoaster markets, Nikkei rebounds 10%

MORNING BID AMERICAS-Rollercoaster markets, Nikkei rebounds 10% A look at the day ahead in U.S. and global markets from Mike Dolan The speed and scale of Tuesday's 10% Tokyo bounce after its worst day in 37 years suggests the wild global market swings of the past week are more rooted in speculative churn than economic fright. While that's only partly reassuring - as persistent market turbulence can itself sap economic activity - there's good reason to believe a slowing U.S.
A
C
N
U
W
J
U
U
U
F
F
D
I
J
M
S
B

STERIS plc <STE.N> expected to post earnings of $1.98 a share - Earnings Preview

STERIS plc expected to post earnings of $1.98 a share - Earnings Preview STERIS plc STE.N , STE is expected to show a fall in quarterly revenue when it reports results on August 6 for the period ending June 30 2024 The Dublin Ireland; Republic of-based company is expected to report a 0.9% decrease in revenue to $1.272 billion from $1.28 billion a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.